EUVIMEDEUVIMED entdecken
Open Access

Sex-dimorphic effects of glucose transporter-2 gene knockdown on hypothalamic primary astrocyte phosphoinositide-3-kinase (PI3K)/protein kinase B (PKB/Akt)/mammalian target of rapamycin (mTOR) cascade protein expression and phosphorylation

Madhu Babu Pasula, Subash Sapkota, Paul W Sylvester, Karen P Briski

Molecular and Cellular Endocrinology · 2024

DOI: 10.1016/j.mce.2024.112341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024. Verfasst von Madhu Babu Pasula und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA. Hauptthemen laut MEDLINE: Astrocytes, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Gene Knockdown Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucose transporter-2 (GLUT2), a unique high capacity/low affinity, highly efficient membrane transporter and sensor, regulates hypothalamic astrocyte glucose phosphorylation and glycogen metabolism. The phosphoinositide-3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway participates in glucose homeostasis, but its sensitivity to glucose-sensory cues is unknown. Current research used a hypothalamic astrocyte primary culture model to investigate whether glucoprivation causes PI3K/Akt/mTOR pathway activation in one or both sexes by GLUT2-dependent mechanisms. Glucoprivation did not alter astrocyte PI3K levels, yet up-regulated both phosphorylated derivatives in female and down-regulated male p60 phosphoprotein expression. GLUT2 siRNA pretreatment diminished glucoprivic patterns of PI3K and phospho-PI3K expression in each sex. Astrocyte Akt and phospho-Akt/Thr308 proteins exhibited divergent, sex-contingent responses to GLUT2 gene knockdown or glucoprivation. GLUT2 siRNA pretreatment exacerbated glucoprivic-associated Akt diminution in the female, and either amplified (male) or reversed (female) glucoprivic regulation of phospho-Akt/Thr308 expression. GLUT2 gene silencing down- (male) or up-(female) regulated mTOR protein, and phospho-mTOR protein in male. Male astrocyte mTOR and phospho-mTOR profile were refractory to glucoprivation, but glucose-deprived females showed GLUT2-independent mTOR inhibition and GLUT2-dependent phospho-mTOR up-augmentation. Results identify a larger number of glucoprivic-sensitive PI3K/Akt/mTOR pathway proteins in female versus male astrocytes, and document divergent responses of common glucose-sensitive targets. GLUT2 stimulates phosphoPI3K protein expression in each sex, but imposes differential control of PI3K, Akt, phospho-Akt/Thr308, mTOR, and phospho-mTOR profiles in male versus female. Data implicate GLUT2 as a driver of distinctive pathway protein responses to glucoprivation in female, but not male.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktGene Knockdown TechniquesGlucose Transporter Type 2Signal TransductionHypothalamusSex CharacteristicsAnimalsMaleFemalePhosphorylationRats, Sprague-DawleyGlucoseCells, CulturedPhosphatidylinositol 3-KinasesRats

Stichwörter der Autor:innen

AktGLUT2GlucoprivationPI3KmTOR

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktGlucose Transporter Type 2GlucosePhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA.
  • School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA. Electronic address: briski@ulm.edu.

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Pasula, M. B., Sapkota, S., Sylvester, P. W., & Briski, K. P. (2024). Sex-dimorphic effects of glucose transporter-2 gene knockdown on hypothalamic primary astrocyte phosphoinositide-3-kinase (PI3K)/protein kinase B (PKB/Akt)/mammalian target of rapamycin (mTOR) cascade protein expression and phosphorylation. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2024.112341

Vancouver

Pasula MB, Sapkota S, Sylvester PW, Briski KP. Sex-dimorphic effects of glucose transporter-2 gene knockdown on hypothalamic primary astrocyte phosphoinositide-3-kinase (PI3K)/protein kinase B (PKB/Akt)/mammalian target of rapamycin (mTOR) cascade protein expression and phosphorylation. Molecular and Cellular Endocrinology. 2024. doi:10.1016/j.mce.2024.112341

BibTeX
@article{Pasula2024,
  author = {Pasula, Madhu Babu and Sapkota, Subash and Sylvester, Paul W and Briski, Karen P},
  title = {Sex-dimorphic effects of glucose transporter-2 gene knockdown on hypothalamic primary astrocyte phosphoinositide-3-kinase (PI3K)/protein kinase B (PKB/Akt)/mammalian target of rapamycin (mTOR) cascade protein expression and phosphorylation},
  journal = {Molecular and Cellular Endocrinology},
  year = {2024},
  doi = {10.1016/j.mce.2024.112341}
}
Kostenlos starten →